ISOPROTERENOL HYDROCHLORIDE INJECTION USP DIN 02502615
Status: Marketed
Holder: MARCAN PHARMACEUTICALS INC
Molecule: ISOPROTERENOL HYDROCHLORIDE
Available to quote
Health Canada record
| Active ingredient(s) | ISOPROTERENOL HYDROCHLORIDE 0.2 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C01CA02 ISOPRENALINE |
| Original market date | 11-Dec-2020 |
| Current status date | 11-Dec-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Marcan Pharmaceuticals Inc. — licence 101909, currently licensed, last inspection rating C (2024-05-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ISOPROTERENOL HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00897639 | ISOPROTERENOL HYDROCHLORIDE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | ISOPROTERENOL HYDROCHLORIDE 0.2 MG | Marketed |
| 02502623 | ISOPROTERENOL HYDROCHLORIDE INJECTION USP | MARCAN PHARMACEUTICALS INC | Solution | ISOPROTERENOL HYDROCHLORIDE 1 MG | Marketed |
| 02290049 | ISOPROTERENOL HYDROCHLORIDE INJECTION USP | OMEGA LABORATORIES LIMITED | Solution | ISOPROTERENOL HYDROCHLORIDE 0.2 MG | Cancelled Pre Market |
| 01928449 | ISUPREL MISTOMETER 125MCG/AEM | STERLING WINTHROP INC. | Metered-Dose Aerosol | ISOPROTERENOL HYDROCHLORIDE 125 MCG | Cancelled Post Market |
| 02017660 | ISUPREL MISTOMETER AEM 0.25% | SANOFI CANADA, INC. | Metered-Dose Aerosol | ISOPROTERENOL HYDROCHLORIDE 0.25 % | Cancelled Post Market |
International API supply for ISOPROTERENOL HYDROCHLORIDE
11 active FDA Drug Master Files.
Request a quote for ISOPROTERENOL HYDROCHLORIDE INJECTION USP